Taken together, these observations suggest that therapies aimed at re-establishing TLR3 signaling or its functional consequences may provide an effective means to protect susceptible patients from suffering the fatal consequences of viral myocarditis. The gene discussed is TLR3; the disease is viral myocarditis.